An Overview of Amyotrophic Lateral Sclerosis
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
An Overview of Amyotrophic Lateral Sclerosis
-
Narrated by:
-
Written by:
Amyotrophic lateral sclerosis (ALS), which affects about 25 000 individuals in the US, causes progressive weakness but has varied presentations. Several FDA-approved medications are now available for ALS. Author John Ravits, MD, of UC San Diego School of Medicine joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss current evidence regarding diagnosis and treatment of ALS.
Related Content:
- Amyotrophic Lateral Sclerosis
- Pridopidine in Amyotrophic Lateral Sclerosis
- What Is Amyotrophic Lateral Sclerosis?
- CNM-Au8 in Amyotrophic Lateral Sclerosis
- Safety and Efficacy of PrimeC in Amyotrophic Lateral Sclerosis
- Traumatic Brain Injury and Risk of Amyotrophic Lateral Sclerosis
adbl_web_anon_alc_button_suppression_c
No reviews yet